Eur Rev Med Pharmacol Sci 2020; 24 (7): 3440-3441
DOI: 10.26355/eurrev_202004_20797

Defining the burden of olfactory dysfunction in COVID-19 patients

M. Ralli, A. Di Stadio, A. Greco, M. de Vincentiis, A. Polimeni

Department of Sense Organs, Sapienza University of Rome, Italy. massimo.ralli@uniroma1.it

Free PDF Download

To cite this article

M. Ralli, A. Di Stadio, A. Greco, M. de Vincentiis, A. Polimeni
Defining the burden of olfactory dysfunction in COVID-19 patients

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 7
Pages: 3440-3441
DOI: 10.26355/eurrev_202004_20797

Keywords Related articles:

  1. Are probiotics effective adjuvant therapeutic choice in patients with COVID-19?
  2. How to restructure the management of Italian oncological patients during and after COVID-19 pandemic?
  3. Mortality rate and gender differences in COVID-19 patients dying in Italy: A comparison with other countries
  4. Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA)
  5. Severe COVID-19 patients with liver injury: a seven-case series